fda compounding semaglutide warning november 2025 September 15, 2025: Telehealth company must stop implying its compounded GLP-1 is FDA-approved, warns – Partnership for Safe Medicines 🚨 FDA Moves to Permanently

Try our GLP-1 Weight Loss program

WHO GLP-1 Treatments: The World Health Organization has issued new guidelines endorsing GLP-1 agonists as essential treatments for obesity, highlighting the urgent need for action against the rising global obesity epidemic affecting over one billion people and posing serious health risks.

The approval of semaglutide for chronic weight management has fundamentally changed obesity medicine, and semaglutide training for physicians has become an urgent clinical priority

Over the last few years,glucagon-like peptide-1 (GLP-1) receptor agonistsTrusted Sourcehave been growing in popularity for not only treatingtype 2 diabetesbut also forweight loss.

At F45 Training, weve teamed up with the worlds leaders in fitness, health, and wellness to supercharge your holistic lifestyle journey

Learn how timing can enhance your journeyread the article now!